REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Ortho-hydroxybenzoic Acid (i.e., Salicyclic Acid) Or Derivative Doai Ortho-hydroxybenzoic Acid (i.e., Salicyclic Acid) Or Derivative DoaiOrtho-hydroxybenzoic Acid (i.e., Salicyclic Acid) Or Derivative Doai patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.02/01/07 - 20070027119 - Antibacterial composition and method of use Use of a liquid composition comprising at least two agents selected from lactic acid, salicylic acid, benzyl alcohol, and/or low molecular weight aliphatic alcohol having less than five carbon atoms for the manufacture of an antimicrobial solution is disclosed. In a preferred embodiment, the antimicrobial solution is formulated as a ... 01/04/07 - 20070004686 - Attractant for apple fruit moth and other insect pests of apple The present invention relates to the use of behaviour modifying volatile plant compounds of rowan Sorbus aucuparia and apple Malus domestica for a determination of a population or controlling pest insects on apple, in particular apple fruit moth Argyresthia conjugella Zeller (Lepidoptera, Argyresthiidae) and codling moth Cydia Pomonella L. (Lepidoptera, ... 11/23/06 - 20060264409 - Compositions and methods of treatment for inflammatory diseases Inflammatory bowel diseases are represented by two idiopathic disorders, which include ulcerative colitis and Crohn's disease. Ulcerative colitis is restricted to the colon and involves uncertain and inflammation of the lining (mucosa) of the large intestine. Crohn's disease, on the other hand, can involve the mucosa of the small and/or ... 10/05/06 - 20060223787 - Modified release formulations and methods of treating inflammatory bowel disease Methods and formulations for treating inflammatory bowel disease are disclosed. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of 4-aminosalicylic acid and/or 5-aminosalicylic acid, and pharmaceutically acceptable salts and pro-drugs thereof, to affected areas of the intestine, i.e., distal gut. The ... 09/14/06 - 20060205699 - Topical treatment for psoriasis The present treatment cocktail represents a dual mode topical treatment for the skin disease psoriasis. The composition contains at least an Analgesic Agent and a Drying Agent as selected from the group disclosed herein. The agents heal psoriatic plaques by promoting the exfoliation of existing psoriatic plaques and preventing additional ... 08/24/06 - 20060189583 - Aryl dicarboxamides The present invention is related to aryl dicarboxamides of formula (I) and use thereof for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholes-terolemia, polycystic ovary syndrome (PCOS). In particular, ... 07/06/06 - 20060148767 - Use of acyl salicylates as heat shock inducers The invention relates to acyl-salicylates as heat shock response inducers and the use thereof as active ingredients in cosmetic and/or pharmaceutical preparations. ... 06/22/06 - 20060135489 - Chemical compounds containing tocopherol and at least one additional pharmaceutical active substrate and R′, R″ and R′″ are equal to H or methyl stands for tocopherol and A stands for C═X, SOm, X or CH2, whereby X is equal to 0, S or NR1 (when n≧1) or S or NR1 (when n=0), and B means a grouping X—R2—Y with Y equal to ... 06/15/06 - 20060128676 - Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain Disclosed herein are compositions of nicotinic agonists, salts, hydrates, solvates or prodrugs thereof and therapeutic agents salts, hydrates, solvates or prodrugs thereof, pharmaceutical compositions thereof and methods of using these compositions and pharmaceutical compositions thereof to treat or prevent disease or pain in a subject. Also disclosed are methods of ... 02/16/06 - 20060035870 - Carboxylic acid derivatives as ip antagonists R4is —COOH or tetrazolyl; A, B, m, n, and r are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and ... 12/29/05 - 20050288263 - 2-(&agr;-hydroxypently) benzoate and its preparation and use The invention relates to new synthetic 2-(α-hydroxypentyl) benzoates, their preparation and pharmaceutical compositions containing such salts as active ingredients. The invention also relates to the use of the compounds for preventing and treating cardioischemia, cerebroischemia and cardiac or cerebral arterial occlusion (obstruction), etc. ... 11/17/05 - 20050256091 - Compositions based on cupric salts cupric salts and their use for controlling phytopathogens Fungicidal compositions are described, containing one or more salts of derivatives of salicylic acid having formula (I): in any molar ratio, with at least one fungicidal compound not corresponding to a salt of derivatives of salicylic acid having formula (I). ... 10/27/05 - 20050239754 - S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine salicylate monohydrate crystalline salt A crystalline salicylate monohydrate salt of S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine is disclosed. A method to make crystalline S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine is further disclosed. In addition, methods of use for crystalline S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine are disclosed ... 10/06/05 - 20050222096 - Methods of screening for compounds that modulate tafia activity, compounds, and methods of using the compounds Provided are methods of screening compounds for any aspirin-related activity other than TAFI inhibition, and also for non-inhibition of TAFI. Compounds identified by the screening methods can be used to treat, prevent or manage in a patient pain, fever, colon cancer, pancreatic cancer or an inflammatory, platelet aggregation, fibrinolytic or ... 10/06/05 - 20050222095 - Anti-bacterial plant compositions The invention provides a pharmaceutical composition which comprises a pharmaceutical carrier and at least one compound selected from the group consisting of cobaltacene-octgomet, stigmastan-3,5-diene, galoxolide, benzyl salicylate, eucalyptol, and α-pinene. Also provided is a method of preparing a composition having antimicrobial activity comprising extracting a plant material in an organic ... 08/25/05 - 20050187200 - Methods and reagents for the treatment of inflammatory disorders The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering a tricyclic compound and, optionally, a corticosteroid or other compound to the patient. The invention also features a pharmaceutical composition containing a tricyclic compound and a corticosteroid or other ... 07/28/05 - 20050164994 - Treatment of genitourinary tract disorders Genitourinary system disorders are treated with therapeutic agents, and optionally further with radiation treatments. ... 07/21/05 - 20050159394 - Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets Novel peripheral antinociceptive compounds are disclosed having a pharmacophore unit that target small-diameter nerve fibers that transmit signals of pain and discomfort from the soma and viscera. By acting on this target, the pharmacophore unit obtunds pain and diminishes hyper-reflexia from organs such as the skin, the respiratory tract, the ... 07/07/05 - 20050148554 - Anti-inflammatory and anti-thrombotic compounds and their compositions The invention also encompasses certain pharmaceutical compositions and methods for treatment of cyclooxygenases (COX-1 and COX-2) mediated diseases comprising the use of compounds of Formula I. The above compounds may be used as a combination therapy with low-dose aspirin, NSAIDs, or selective COX-2 inhibitors to treat chronic cyclooxygenases mediated diseases ... 06/02/05 - 20050119237 - Non-malignant disease treatment with ras antagonists Disclosed is a method for inhibiting Ras-induced or mediated proliferation of cells associated with a non-malignant disease, disorder or pathological condition. The method entails administering to a patient a Ras antagonist in an amount effective to inhibit the proliferation. The invention is particularly applicable to diseases characterized by a proliferation ... 06/02/05 - 20050119236 - Cancer treatments and pharmaceutical compositions therefor wherein R is selected from the group consisting of H, carboxyl (—CO2H), hydroxyl, amino or esters (—CO2R′) wherein R′ is selected from the group consisting of alkoxy, haloalkyl, alkenyl, and cycloalkyl wherein the alkyl groups have from 1-8 carbons or CH3CH2(OCH2CH2)n— or CH3CH2CH2(OCH2CH2CH2)n— or (CH3)2CH—(OCH(CH3)CH2)n— wherein n is from 1-3, ... ### FreshPatents.com Support |